← Back to Patent Explorer
US4917686A Expired / Lapsed US ⏱️ 0.0 years remaining

Antimicrobial device and method

Assignee: Colorado Biomedical Inc
•
Filing: 1987-11-23
•
Granted: 1990-04-17
•
Expires: 2007-11-23
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A medical device made from a material capable of being implanted in living tissue or transcutaneously inserted therein or of long term in-dwelling therein, which exhibits persistent antimicrobial activity in use, and containing a body of a synthetic or naturally occurring material having side surfaces and being capable of being swelled by penetration of a swelling agent and which has been subjected to such a swelling agent which contains completely dissolved therein at least one antimicrobial agent as a solute, the surfaces being contacted by such swelling agent for a sufficient period of time to promote swelling of the matrix of a body of material and thereby permit diffusion and migration of the solution containing the selected antimicrobial agent solute into the interstitial spaces of the body of material at the molecular level by the action of the swelling agent within the body of material, and the solvent being capable of being removed from the solute in the body of material by evaporation and after removal of the solvent the body of material being capable of returning substantially to its original size and shape with the antimicrobial agent substantially uniformly deposited therein for subsequent continuous migration to and diffusion through the surfaces.

Inventors

  • 👤 Roger Bayston
  • 👤 Nancy J. Grove

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 02:15
CPC Classifications
A; A61; A61M; A61M5/00; A61M5/178; A61M5/31; A61M5/315; A61L; A61L29/00; A61L29/14; A61L29/16; A61L27/00; A61L27/50; A61L27/54; A61L2300/00; A61L2300/40; A61L2300/404; A61L2300/406; A61L2300/45

Claims Analysis

Total Claims: 18
Claim 1
Independent Claim 263 words
A medical device made from a material capable of being implanted in living tissue and of long indwelling therein, which exhibits persistent antimicrobial activity in use, and comprises: a body of a polymeric material which is capable of being swelled by a swelling agent and which has been subject to such a swelling agent which contains completely dissolved therein one or more antimicrobial agents as a solute, said body being contacted by such swelling agent for a sufficient period of time to promote swelling of the body of material to enlarge the normal size and intermolecular spaces therewithin thereby causing diffusion and migration of the solution containing the selected antimicrobial agent(s) into the enlarged intermolecular spaces of the body of material by the action of the swelling agent within the body of material and said solvent being removed from said solute in the matrix of the body of material by evaporation with said solute remaining in the intermolecular spaces of the body of material and after removal of said solvent said body of material returning substantially to its original size and shape and having substantially normal intermolecular spaces with said antimicrobial agent substantially uniformly deposited therein for subsequent continuous molecular migration to and molecular diffusion through the surfaces to provide persistent antimicrobial activity at the surfaces of during use in the human body, said medical device subject to autoclaving prior to use; and said polymeric material and said antimicrobial agent(s) selected so that the rate of continuous molecular migration and molecular diffusion remains the same or is retarded by the effects of autoclaving.
Claim 2
Dependent Claim 263 words
A medical device made from a material capable of being implanted in living tissue and of long indwelling therein, which exhibits persistent antimicrobial activity in use, and comprises: a body of a polymeric material which is capable of being swelled by a swelling agent and which has been subject to such a swelling agent which contains completely dissolved therein one or more antimicrobial agents as a solute, said body being contacted by such swelling agent for a sufficient period of time to promote swelling of the body of material to enlarge the normal size and intermolecular spaces therewithin thereby causing diffusion and migration of the solution containing the selected antimicrobial agent(s) into the enlarged intermolecular spaces of the body of material by the action of the swelling agent within the body of material and said solvent being removed from said solute in the matrix of the body of material by evaporation with said solute remaining in the intermolecular spaces of the body of material and after removal of said solvent said body of material returning substantially to its original size and shape and having substantially normal intermolecular spaces with said antimicrobial agent substantially uniformly deposited therein for subsequent continuous molecular migration to and molecular diffusion through the surfaces to provide persistent antimicrobial activity at the surfaces of during use in the human body, said medical device subject to autoclaving prior to use; and said polymeric material and said antimicrobial agent(s) selected so that the rate of continuous molecular migration and molecular diffusion remains the same or is retarded by the effects of autoclaving.
Claim 3
Dependent Claim 14 words
The medical device of claim 1 wherein: the selected material is a silicone elastomer.
Claim 4
Dependent Claim 18 words
The medical device of claims 1 and 2 wherein: the swelling agent is chloroform or its chemical homologs.
Claim 5
Dependent Claim 23 words
The medical device of claim 3 wherein: the antimicrobial agent is selected from the group consisting of rifampin, clindamycin hydrochloride and mixtures thereof.
Claim 6
Dependent Claim 31 words
The medical device of claim 4 wherein: each selected antimicrobial is dissolved in the swelling agent in an amount of about 0.1% to 1.0% weight by volume of the swelling agent.
Claim 7
Dependent Claim 24 words
The medical device of claim 1 wherein: said autoclaving occurs at about 250° F. and at a pressure of about 15 psi above atmosphere.
Claim 8
Independent Claim 205 words
A method of infusing antimicrobials into the body of implantable and long in-dwelling medical devices containing a body of elastomer material comprising the steps of: completely contacting the surfaces of the body of elastomer with a solution comprising a swelling agent as a solvent and at least one antimicrobial agent as a solute dissolved therein, said elastomer and said at least one antimicrobial agent selected so that the rate of diffusion of the antimicrobial agent out of the medical device will remain the same or be retarded by the effects of autoclaving. maintaining contact between the solution and the surfaces for a sufficient period of time for the solution to completely penetrate and swell and to enlarge the normal intermolecular spaces of the body of material and to diffuse the solution into the enlarged intermolecular spaces provided by the swelling; evaporating the solvent from the solution and to thereby deposit and retain the antimicrobial agent within the intermolecular spaces of the body of elastomer while causing the body of material to return substantially to its original physical shape and condition with substantially normal intermolecular spaces; and rinsing the surfaces of the treated body of material and autoclaving the treated body of material prior to use.
Claim 9
Independent Claim 205 words
A method of infusing antimicrobials into the body of implantable and long in-dwelling medical devices containing a body of elastomer material comprising the steps of: completely contacting the surfaces of the body of elastomer with a solution comprising a swelling agent as a solvent and at least one antimicrobial agent as a solute dissolved therein, said elastomer and said at least one antimicrobial agent selected so that the rate of diffusion of the antimicrobial agent out of the medical device will remain the same or be retarded by the effects of autoclaving. maintaining contact between the solution and the surfaces for a sufficient period of time for the solution to completely penetrate and swell and to enlarge the normal intermolecular spaces of the body of material and to diffuse the solution into the enlarged intermolecular spaces provided by the swelling; evaporating the solvent from the solution and to thereby deposit and retain the antimicrobial agent within the intermolecular spaces of the body of elastomer while causing the body of material to return substantially to its original physical shape and condition with substantially normal intermolecular spaces; and rinsing the surfaces of the treated body of material and autoclaving the treated body of material prior to use.
Claim 10
Dependent Claim 31 words
The method of claim 7 wherein: the antimicrobial agent is selected from the group of broad spectrum antibiotics consisting of rifampin, clindamycin hydrochloride and mixtures thereof and is dissolved in chloroform.
Claim 11
Dependent Claim 23 words
The method of claim 7 or 8 wherein: said autoclaving occurs at about 250° F. and at about 15 psi above atmospheric pressure.
Claim 12
Dependent Claim 49 words
An antimicrobial composition capable of being infused into the body of a medical device made of silicone elastomer or the like comprising a swelling agent for the silicone elastomer, a solvent, and solute consisting of rifampin and clindamycin hydrochloride, said swelling agent being chloroform or one of its homologs.
Claim 13
Dependent Claim 49 words
An antimicrobial composition capable of being infused into the body of a medical device made of silicone elastomer or the like comprising a swelling agent for the silicone elastomer, a solvent, and solute consisting of rifampin and clindamycin hydrochloride, said swelling agent being chloroform or one of its homologs.
Claim 14
Dependent Claim 151 words
A medical device for use in the human body and comprising: a body of silicone elastomer having a matrix of polymeric molecules; two antimicrobial agents substantially uniformly dispersed throughout said body of polymeric material and providing a substantially uniform molecular dispersion of said antimicrobial agents within the normal intermolecular spaces of said body of silicone elastomer; and said body of silicone elastomer and said antimicrobial agents therein effectively providing a solid solution of molecules of polymeric material and molecules of antimicrobial agent having a concentration and concentration distribution of antimicrobial agent such as to cause solid state diffusion of the molecules of the antimicrobial agent toward and through the intermolecular spaces of the body of polymeric material for sufficient period of time to provide effective protection against infection after implant in the human body, the rate of said solid diffusion having remained the same or been retarded by autoclaving such device.
Claim 15
Dependent Claim 151 words
A medical device for use in the human body and comprising: a body of silicone elastomer having a matrix of polymeric molecules; two antimicrobial agents substantially uniformly dispersed throughout said body of polymeric material and providing a substantially uniform molecular dispersion of said antimicrobial agents within the normal intermolecular spaces of said body of silicone elastomer; and said body of silicone elastomer and said antimicrobial agents therein effectively providing a solid solution of molecules of polymeric material and molecules of antimicrobial agent having a concentration and concentration distribution of antimicrobial agent such as to cause solid state diffusion of the molecules of the antimicrobial agent toward and through the intermolecular spaces of the body of polymeric material for sufficient period of time to provide effective protection against infection after implant in the human body, the rate of said solid diffusion having remained the same or been retarded by autoclaving such device.
Claim 16
Dependent Claim 15 words
The invention of claim 11 wherein: the swelling agent is chloroform or a chemical homolog.
Claim 17
Dependent Claim 24 words
The invention of claim 11 and 12 wherein: the antimicrobial agents are selected from the group consisting of rifampin, clindamycin hydrochloride and mixtures thereof.
Claim 18
Dependent Claim 30 words
The invention of claim 13 wherein: each of the antimicrobial agents are dissolved in chloroform in the amount of 0.1% to 1.0% by weight of agent to volume of chloroform.

References Cited (Backward Citations)

US4392848A Cited
US4343788A Cited
US4513083A Cited
US4686124A Cited
US4605564A Cited
US4612337A Cited
US4713402A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1993-04-16 1993-10-16 1994-04-17 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1997-04-16 1997-10-16 1998-04-17 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2001-04-16 2001-10-16 2002-04-17 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag